1921
Volume 102, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0754
2019-10-28
2020-08-04
Loading full text...

Full text loading...

/deliver/fulltext/14761645/102/1/tpmd190754.html?itemId=/content/journals/10.4269/ajtmh.19-0754&mimeType=html&fmt=ahah

References

  1. White AC, Coyle CM, Rajshekhar V, Singh G, Hauser WA, Mohanty A, Garcia HH, Nash TE, 2018. Diagnosis and treatment of neurocysticercosis: 2017 clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical medicine and Hygiene (ASTMH). Am J Trop Med Hyg 98: 945966.
    [Google Scholar]
  2. Garcia HH et al., 2014. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis 14: 687695.
    [Google Scholar]
  3. Moyano LM et al., 2016. High prevalence of asymptomatic neurocysticercosis in an endemic rural community in Peru. PLoS Negl Trop Dis 10: e0005130.
    [Google Scholar]
  4. Del Brutto OH, Arroyo G, Del Brutto VJ, Zambrano M, García HH, 2017. On the relationship between calcified neurocysticercosis and epilepsy in an endemic village: a large-scale, computed tomography-based population study in rural Ecuador. Epilepsia 58: 19551961.
    [Google Scholar]
  5. Fleury A et al., 2003. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 22: 139145.
    [Google Scholar]
  6. Marcin Sierra M et al., 2017. Extraparenchymal neurocysticercosis: demographic, clinicoradiological, and inflammatory features. PLoS Negl Trop Dis 11: e0005646.
    [Google Scholar]
  7. Sotelo J, Marin C, 1987. Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. J Neurosurg 66: 686689.
    [Google Scholar]
  8. Sorvillo FJ, DeGiorgio C, Waterman SH, 2007. Deaths from cysticercosis, United States. Emerg Infect Dis 13: 230235.
    [Google Scholar]
  9. Nash T, O’Connell E, Hammoud D, Wetzler L, Ware J, Mahanty S, 2020. Natural history of treated subarachnoid racemose neurocysticercosis. Am J Trop Med Hyg 102: 7889.
    [Google Scholar]
  10. Osorio R, Carrillo-Mezo R, Romo ML, Toledo A, Matus C, González-Hernández I, Jung H, Fleury A, 2019. Factors associated with cysticidal treatment response in extraparenchymal neurocysticercosis. J Clin Pharmacol 59: 548556.
    [Google Scholar]
  11. Serpa JA, Graviss EA, Kass JS, White AC, 2011. Neurocysticercosis in Houston, Texas: an update. Medicine (Baltimore) 90: 8186.
    [Google Scholar]
  12. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F, 1984. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 310: 10011007.
    [Google Scholar]
  13. Escobedo F, Penagos P, Rodriguez J, Sotelo J, 1987. Albendazole therapy for neurocysticercosis. Arch Intern Med 147: 738741.
    [Google Scholar]
  14. Carpio A, Santillán F, León P, Flores C, Hauser WA, 1995. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 155: 19821988.
    [Google Scholar]
  15. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, Herrera G, Evans CA, Gonzalez AE; Cysticercosis Working Group in Peru, 2004. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 350: 249258.
    [Google Scholar]
  16. Carpio A, Kelvin E, Bagiella E, Leslie D, Leon P, Andrews H, Hauser W, 2008. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 79: 10501055.
    [Google Scholar]
  17. Zhao BC et al., 2016. Albendazole and corticosteroids for the treatment of solitary cysticercus granuloma: a network meta-analysis. PLoS Negl Trop Dis 10: e0004418.
    [Google Scholar]
  18. Agapejev S, Da Silva MD, Ueda AK, 1996. Severe forms of neurocysticercosis: treatment with albendazole. Arq Neuropsiquiatr 54: 8293.
    [Google Scholar]
  19. Proaño JV, Madrazo I, Avelar F, Lopez-Felix B, Diaz G, Grijalva I, 2001. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med 345: 879885.
    [Google Scholar]
  20. Nash TE, Ware JM, Coyle CM, Mahanty S, 2019. Etanercept to control inflammation in the treatment of complicated neurocysticercosis. Am J Trop Med Hyg 100: 609616.
    [Google Scholar]
  21. Kelley R, Duong DH, Locke GE, 2002. Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery 50: 757761; discussion 761–762.
    [Google Scholar]
  22. Suastegui Roman RA, Soto-Hernandez JL, Sotelo J, 1996. Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J Neurosurg 84: 629633.
    [Google Scholar]
  23. Proaño JV, Torres-Corzo J, Rodríguez-Della Vecchia R, Guizar-Sahagun G, Rangel-Castilla L, 2009. Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv Syst 25: 14671475.
    [Google Scholar]
  24. Fleury A, Garcia E, Hernández M, Carrillo R, Govezensky T, Fragoso G, Sciutto E, Harrison LJ, Parkhouse RM, 2013. Neurocysticercosis: HP10 antigen detection is useful for the follow-up of the severe patients. PLoS Negl Trop Dis 7: e2096.
    [Google Scholar]
  25. O’Connell EM, Harrison S, Dahlstrom E, Nash T, Nutman TB, 2019. A novel, highly sensitive qPCR assay for the diagnosis of subarachnoid and ventricular neurocysticercosis and for assessing response to treatment. Clin Infect Dis. Available at: https://doi.org/10.1093/cid/ciz541.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0754
Loading
  • Received : 30 Sep 2019
  • Accepted : 30 Sep 2019
  • Published online : 28 Oct 2019

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error